Speakers

Throughout his career, Dr Moyes has been involved in investigating host-microbe interactions and the role of both microbe and host innate immune responses in these interactions.  

He gained his PhD from Imperial College London, before working at the Kennedy Institute of Rheumatology investigating the link between microbes and rheumatoid arthritis.  

At King’s College, he was part of a team that identified the central mechanisms by which epithelial cells discriminate between commensal (harmless) and invasive (disease-causing) forms of Candida albicans.  This work lead eventually to the discovery of the novel Candidalysin toxin and its role in both disease and protection at mucosal surfaces.  

His interests have evolved to investigate the role of the microbiome in causing disease. The Moyes lab studies the interactions between the human host and the microbiota that reside at the different mucosal surfaces, including bacteria, fungi and viruses. They are investigating whether changes in microbial communities associated with disease are a symptom of the disease, or whether they play a role in driving the disease process.